Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Coagulopathy: A Possible Mechanism of Terlipressin-induced Peripheral Ischemic Complications – Evidence from Published Case Reports

    Phulen Sarma1, Vidya Mahalmani1, Shammy Chandel1, Subodh Kumar1, Hardeep Kaur1, Ajay Prakash1, Deba Prasad Dhibar1, Bikash Medhi1★★ Corresponding author

    1. 1Departments of Pharmacology, Neurosurgery and Internal Medicine, PGIMER, Chandigarh, India.

    CORRESPONDENCE

    Bikash Medhi

    Departments of Pharmacology, Neurosurgery and Internal Medicine, PGIMER, Chandigarh, India.

    drbikashus@yahoo.com

    Received: 16-11-2018; Revised: 30-11-2018; Accepted: 12-12-2018.

    Volume 9, Issue 4 · pp. 198–9 · PUBLISHED 2018 · DOI: 10.4103/jpp.JPP_127_18

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    The coagulopathy may be the result of release of Von willebrand factor (VWF) or direct platelet activation by vasopressin, which may be responsible in addition to other factors for the cutaneous necrotic lesions.

    KEYWORDS

      Open in new tab

      REFERENCES

      As published

      Showing references and in-text citations exactly as published.

        Cite this article

        SELECT FORMAT

        Sarma, P., Mahalmani, V., Chandel, S., Kumar, S., Kaur, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2018). Coagulopathy: A Possible Mechanism of Terlipressin-induced Peripheral Ischemic Complications – Evidence from Published Case Reports. Journal of Pharmacology and Pharmacotherapeutics, 9(4), 198–9. https://doi.org/10.4103/jpp.JPP_127_18